Fig. 3: Overview of structural variation profiles in the seven cohorts.
From: Gut microbial structural variation associates with immune checkpoint inhibitor response
a The number of structural variations (SVs) present in each species within the UK cohorts from studies on melanoma. b The proportion of dSV and vSVs and total SV number of the UK cohort from studies on melanoma. c Principal component 1 and principal component 2 of SV makeup within five cohorts from USA or UK. d The number of SVs present in each species within the France cohorts from studies on NSCLC or RCC. e The proportion of dSV and vSVs and total SV number of the France cohorts from studies on NSCLC or RCC. f Principal component 1 and principal component 2 of SV makeup within two cohorts from France.
